Using recombinant human G-CSF to treat chemotherapy-induced neutropenia over 3 decades: What is next?

<p>Chemotherapy-Induced Neutropenia (CIN) is a potentially fatal side effect of cancer treatment, affecting > 50% of cancer patients treated with chemotherapy. Clinical use of recombinant human granulocyte colony-stimulating factor (rhG-CSF) has allowed for primary and secondary prophylaxis...

Full description

Saved in:
Bibliographic Details
Main Authors: Jason Xu (Author), Jonathan Sussman (Author), Jessica Xu (Author), Xing Zhao (Author), Xiao Qiang Yan (Author)
Format: Book
Published: Annals of Bone Marrow Research - Peertechz Publications, 2023-09-12.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!